Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke

@article{Choi2020AlteredCR,
  title={Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke},
  author={Ji-Young Choi and Hye-Kyung Lee and Jung-Hyun Park and Sun-Jung Cho and Munjin Kwon and Chulman Jo and Y. Koh},
  journal={Biochemical and Biophysical Research Communications},
  year={2020},
  volume={528},
  pages={413 - 419}
}
Coronavirus disease 2019 (COVID-19) is a worldwide pandemic. It has a high transmission rate among humans, and is a threat to global public health. However, there are no effective prophylactics or therapeutics available. It is necessary to identify vulnerable and susceptible groups for adequate protection and care against this disease. Recent studies have reported that COVID-19 has angiotensin-converting enzyme 2 (ACE2) as a functional receptor, which may lead to the development of severe… Expand
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
TLDR
The evidence pertaining to ACE2’s relationship to common comorbidities, risk factors, and therapies associated with the susceptibility and severity of COVID-19 is reviewed and gaps of knowledge are highlighted that require further investigation. Expand
Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes
TLDR
Clinicians managing COVID-19 patients should appreciate the potential cardiovascular effects related to the disease process as well as the hematologic effects of CO VID-19 and COvid-19 in heart transplant patients. Expand
COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach
TLDR
The aim of the present study is to elucidate the possible protective role of oxidative preconditioning in aged patients at high risk of developing severe COVID-19 complications, and to search for care and adequate protection against the disease, especially for susceptible and vulnerable groups. Expand
The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms
TLDR
The effects and possible underlying mechanisms of SARS-CoV-2 on ischemic stroke are described and it is hoped that when medical staff treat patients with COVID-19, they would pay attention to the occurrence of isChemic stroke to improve the prognosis of patients with CoV-19. Expand
Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect
TLDR
Whether or not and in which manner the pharmacomodulation of the renin-angiotensin system may had affect the clinical course of the reported six COVID-19 patients affected by stroke has to be still clarified. Expand
The epidemiology and therapeutic options for the COVID-19
TLDR
The current study revisits advances of the virology, epidemiology, clinical features, therapeutic options, and prevention of COVID-19, and the features of asymptomatic carriers are explored. Expand
Mental Health Issues During and After COVID-19 Vaccine Era
The COVID-19 pandemic has persisted for more than a year, and post-COVID-19 sequelae of neurological complications, including direct and indirect effects on the central nervous system (CNS), haveExpand
COVID-19 and stroke: A review
TLDR
The current understanding of stroke in CO VID-19 patients complicated with stroke is presented, and the underlying mechanism between COVID-19 and stroke warrants further study. Expand
SARS-CoV-2 Infection Reaches the Human Nervous System: How?
Without protective and/or therapeutic agents the SARS-CoV-2 infection known as coronavirus disease 2019 (COVID-19) is quickly spreading worldwide. It has surprising transmissibility potential, sinceExpand
Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2
The pandemic caused by SARS-CoV-2 has caused widespread infection and significant mortality across the globe. Combined virology perspective of SARS-CoV-2 with a deep-rooted understanding ofExpand
...
1
2
3
...

References

SHOWING 1-10 OF 53 REFERENCES
COVID-19-Related Stroke
TLDR
There is a rationale to continue to treat with tissue plasminogen activator for COVID-19-related stroke and low molecular weight heparinoids may reduce thrombosis and mortality in sepsis-induced coagulopathy. Expand
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
TLDR
A molecular explanation why SARS-CoV infections cause severe and often lethal lung failure and suggest a rational therapy for SARS and possibly other respiratory disease viruses is provided. Expand
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
TLDR
It is predicted that nicotine exposure through various kinds of smoking can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2 and advocate for higher surveillance and analysis of neurocomplications in infected cases. Expand
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study
TLDR
The findings suggest that older patients with risk factors are more likely to develop CVD and the development of CVD is an important negative prognostic factor which requires further study to identify optimal management strategy to combat the COVID-19 outbreak. Expand
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
TLDR
Investigation of the factors affecting the progression of pneumonia in COVID-19 patients in Wuhan aimed to investigate the risk factors for disease progression and find the optimal treatment regimens for CO VID-19 pneumonia. Expand
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
TLDR
The transcriptional and post-transcriptional regulation of ACE2 and the role of the ACE2/Ang 1-7 axis in cardiac physiology and in the pathophysiology of HF are discussed and the pharmacological and therapeutic potential of enhancing ACE2 /Ang1-7 action as a novel therapy for HF is highlighted. Expand
ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
The renin-angiotensin system (RAS) in brain is a crucial regulator for physiological homeostasis and diseases of cerebrovascular system, such as ischemic stroke. Overactivation of brainExpand
COVID-19 and the cardiovascular system
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acuteExpand
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
TLDR
During the epidemic period of COVID-19, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission. Expand
Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide
TLDR
The results show that Ace2 KO mice have high sensitive, and developed more serious reaction of hepatic inflammation and fibrosis by TAA administration, and the responses lead the pathogenesis of liver fibrosis. Expand
...
1
2
3
4
5
...